Appetite suppressants
Appetite suppressants are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in managing weight loss and obesity-related conditions. These substances act by modulating the appetite-regulating centers in the brain, leading to reduced food cravings and decreased hunger sensations.
One commonly used appetite suppressant API is phentermine. It works by stimulating the release of norepinephrine, a neurotransmitter that affects appetite control. Phentermine enhances satiety and decreases the appetite, thereby promoting weight loss. Another widely prescribed appetite suppressant is liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It increases feelings of fullness and regulates glucose metabolism.
These APIs are typically formulated into oral medications, such as tablets or capsules, for easy administration. They are often prescribed as part of a comprehensive weight management program that includes a balanced diet and exercise.
Appetite suppressants can be effective tools for individuals struggling with excessive food intake or obesity. However, it's important to note that these medications should be used under the guidance of a healthcare professional. They may have potential side effects and contraindications, which need to be evaluated on an individual basis.
In conclusion, appetite suppressant APIs are valuable pharmaceutical ingredients that help control food cravings and reduce hunger, aiding in weight management. When used responsibly and as part of a holistic approach to health, these medications can contribute to achieving and maintaining a healthy weight.
Name | CAS number | Category | Amount of suppliers |
---|---|---|---|
Clobenzorex Hydrochloride | 5843-53-8 | Appetite suppressants | 5 |
Phendimetrazine | 634-03-7 | Appetite suppressants | 1 |
Phentermine | 122-09-8 | Appetite suppressants | 7 |